PrintThe Burrill Report (August 9, 2011): FDA Gives Geron Green Light for Stem Cell Trial(.MP3,10.82 Mb)
.jpg)
The U.S. Food and Drug Administration has given a green light to Geron to proceed with the first trial of a human embryonic stem cell derived therapy in humans. The decision sets into motion a study that had been placed on hold in 2009 over safety concerns after data in a preclinical study of the therapy showed some rats that had received the cells developed cysts. We spoke to Bernie Siegel, executive director of the Genetics Policy Institute, about the significance of the trial, whether too much will be read into its results, and other recent developments in the world of stem cells.August 05, 2010
http://www.burrillreport.com/article-fda_gives_geron_green_light_for_stem_cell_trial.html
.gif)
.png){kind=small}
